Clark Capital Management Group, Inc. Adaptive Biotechnologies Corp Transaction History

Clark Capital Management Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$32.22 - $44.59 $393,212 - $544,176	-12,204 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $1,863 - $3,386	-50 Reduced 0.41%	12,204 $491,000
Q4 2020 Jan 26, 2021	BUY	$45.01 - $65.47 $551,552 - $802,269	12,254 New	12,254 $725,000

228

146M

19.6K

27.2K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.05B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.